Hongyang Lu

13PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPacific Peoples epidemiologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 29, 2026
The efficacy of targeted therapy in ALK-positive non-small-cell lung cancer patients and analysis of MET/PD-L1 expression status.

|Nov 06, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies.

Sizhe Yu, Hui Li, Hongyang Lu

|Oct 31, 2025
Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet.

Meng Zhou, Minghua Li, Qian Cao

|Mar 21, 2024
Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets.

Jiali Gong, Shumin Hu, Qianyun Shan

|Sep 19, 2023
Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single-arm, phase II trial.

Kaiyan Chen, Yanjun Xu, Zhiyu Huang

|Nov 17, 2022
Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review.

Shumin Hu, Jiali Gong, Xiu Zhu

Pageof 3

Frequent Collaborators

2 joint publications

Kaiyan Chen

2 joint publications

Yun Fan

1 joint publications

Xiaoqing Yu

1 joint publications

Wei Hong